KCT0005710
Not yet recruiting
未知
A multicenter randomized exploratory clinical trial to evaluate the effect of bone metabolism and the efficacy of evogliptin and dapagliflozin for blood sugar in the menopause female patients with osteopenia and type 2 diabetes.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyung Hee University Hospital at Gangdong
- Enrollment
- 120
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Postmenopausal women between 40 and 70 years of age with type 2 diabetes patients who are not taking diabetes drugs or who are not controlled by blood sugar at 7\.0%\= HbA1c \< 9\.0% while taking metformin
- •? Menopause corresponds when one or more of the following three conditions are satisfied.
- •? 12 months of amenorrhea
- •? In the case of FSH\=40 mIU/mL in women over 50 years who have undergone hysterectomy or 6 months of amenorrhea
- •? Patients 6 weeks after ovariectomy
- •2\) Lumbar, neck of femur and total femur bone density measurements were \-2\.4\=T\-score\<\-1\.0
- •3\) Obtained written informed consent from a patient
- •4\) Patients who can participate during clinical trials and perform all planned trial procedures and visits.
Exclusion Criteria
- •1\) A person who has taken a diabetes medications other than metformin within 12 weeks, or who is hypersensitivity to DPP4 inhibitors or SGLT2 inhibitors.
- •2\) AST or ALT exceeds 2 times the upper limit of the normal range in laboratory tests
- •3\) Patients with moderate or severe renal impairment, end\-stage renal disease (ESRD) or dialysis
- •4\) Patients whose eGFR (using MDRD formula) calculated using serum creatinine results within 4 weeks before screening or at screening is less than 60 mL/minute/1\.73 m2
- •5\) In case of osteoporosis medication dosage as follows:
- •\- Patients who have ever used bisphosphonate formulations
- •\- Patients who have used female hormones, SERM, denosumab, and parathyroid hormone preparations within 12 months
- •6\) Have bone or mineral metabolic diseases or have received treatment that affects them
- •\- Oral steroid 2\.5mg or more has been continuously taken for more than 3 months from the date of consent
- •\- Continuous use of systemic or inhaled steroids for more than 3 months from the date of consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multi-center randomized controlled clinical trial to examine the clinical, biochemical and antimicrobial effects of a mouth rinse on patients with mild periodontal disease.mild periodontal diseaseJPRN-UMIN000006407Osaka University Graduate School of Dentistry90
Not yet recruiting
Not Applicable
A multi-center randomized controlled clinical trial of massage therapy for mild allergic rhinitis in childreAllergic rhinitis in childrenITMCTR2200005983The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Not yet recruiting
Not Applicable
A multi-center randomized controlled clinical trial of massage in the treatment of moderate to severe allergic rhinitis in childreAllergic rhinitis in childrenITMCTR2200006008The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Recruiting
Not Applicable
Effectiveness of Bi-Sai-Tong solution for moderate to severe allergic rhinitis: a randomized controlled studyITMCTR1900002527Guangdong Provincial Hospital of Chinese Medicine
Recruiting
Not Applicable
A multi centre randomized controlled clinical trial comparing conventional loading of an overdenture on two implants with a bar to immediate loading of an overdenture on two implants with a bar.Edentate proefpersonenOral implantology in edentulous patientsNL-OMON31470Vrije Universiteit92